Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Affibody-based hBCMA x CD16 dual engagers for NK cell-mediated killing of multiple myeloma cells

New Biotechnology(2023)10.1016/j.nbt.2023.09.002Source: DataRank Database

Affibody-based hBCMA x CD16 dual engagers for NK cell-mediated killing of multiple myeloma cells is a research paper published in New Biotechnology (2023). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 2.16)OA: goldTopics (37)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Thorstein Boxaspen,Yumei Diao ORCID,Johan Nilvebrant ORCID,Mizuha Kosugi‐Kanaya ORCID,Minoru Kanaya ORCID

Live enrichment

PubMed:37673373 OpenAlex:https://openalex.org/W4386419543

National Institutes of Health

Grant: 5P01CA111412-04

NK Cells, Their Receptors and Unrelated Donor Transplant

The Research Council of Norway

Grant: 332727

PRIMA - Precision Immunotherapy Alliance

The Research Council of Norway

Grant: 275469

PROGRAMMING NATURAL KILLER CELL FUNCTION THROUGH ORGANELLE COMMUNICATION

FWCI

2.16

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://ars.els-cdn.com/content/image/1-s2.0-S1871678423000456-ga1_lrg.jpg

publisherhttps://ars.els-cdn.com/content/image/1-s2.0-S1871678423000456-ga1_lrg.jpg

publisherhttps://api.elsevier.com/content/article/PII:S1871678423000456?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1871678423000456?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.nbt.2023.09.002

Fields of Study

Monoclonal and Polyclonal Antibodies ResearchImmune Cell Function and InteractionSynthesis and Biological Evaluation03 medical and health sciences0302 clinical medicineHumansMultiple MyelomaKiller Cells, NaturalReceptors, IgGCell Line, TumorB-Cell Maturation AntigenRecombinant Fusion Proteins

MeSH Terms

HumansKiller Cells, NaturalMultiple MyelomaRecombinant Fusion ProteinsReceptors, IgGCell Line, TumorB-Cell Maturation Antigen

Keywords

CD16AntibodyChemistryBispecific antibodyAntigenComputational biologyCancer researchMolecular biologyImmunologyBiologyMonoclonal antibodyMultiple myelomaNK cellsBCMAAffibodyDual Engager570610